Ishaan Tewarie
InvestorVice President at EQT Life Sciences
Amsterdam, Netherlands
Writes $11M – $65M checks · typically $25M
About
Ishaan Tewarie is a Vice President at EQT Group's Life Sciences business line, focusing on healthcare and life sciences investments. He brings experience in investing, company building, and board-level engagement with biotech and medtech companies, supported by an MD and research fellowship at Harvard Medical School. His background includes investment training and think tank participation.
Experience
- EQT GroupVice Presidentcurrent2024 — present
- EQT GroupInvestment Associate2022 — 2024
- Neuros Medical, Inc.Board Membercurrent2025 — present
- Minervax ApSBoard Observercurrent2025 — present
- Vico TherapeuticsBoard Observercurrent2025 — present
- NWO (Dutch Research Council)Selection Committee Membercurrent2024 — present
- Netherlands Academy of EngineeringPartner Council Membercurrent2025 — present
- De ZorgambassadeThink Tank member2025
- TEQ CapitalInvestment Consultant2021 — 2022
- Harvard Medical SchoolDoctoral Research Fellow2019 — 2021Boston, Massachusetts
- Pillar VCFellow2020 — 2021Boston, MA
- MIT Hacking MedicineTeam Member2019 — 2020Cambridge, Massachusetts
- ERBS - Erasmus Research & Business SupportThink Tank Member2018 — 2019Rotterdam Area, Netherlands
- Stichting MECOMCo-Founder and Previous Board Member2016 — 2018Utrecht Area, Netherlands
- Capita Selecta StudieondersteuningGeneral Manager2017 — 2018Rotterdam Area, Netherlands
- Capita Selecta StudieondersteuningRepetitor / Teacher (Medicine)2015 — 2018Rotterdam Area, Netherlands
- the jEURnalistPolitical Columnist2015 — 2017Rotterdam Area, Netherlands
Education
- Harvard Medical SchoolDoctoral Research Fellowship2019 — 2022
- Erasmus University RotterdamMaster of Science (MSc) / MD program, Medicine2017 — 2020
- Erasmus University RotterdamBachelor of Science (BSc), Medicine2013 — 2016
Skills & more
Management1Analytical Skills1Machine LearningStrategic CommunicationsResearchPublic Speaking
Languages Dutch · English · German · Hindi
- LBO modeling training — EQT Group
- Healthcare Ventures — Massachusetts Institute of Technology
- Applied Biostatistics — Harvard Catalyst | The Harvard Clinical and Translational Science Center
- Medical Device Development — Harvard Catalyst | The Harvard Clinical and Translational Science Center
- Tropical Medicine Course — Erasmus MC
- EHBO/BLS — Erasmus MC
From Ishaan's professional profile.
Colleagues at EQT Life Sciences
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Christina Drews
Chief Operating Officer at EQT Life Sciences
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Managing Director at EQT Life Sciences
Network1
Investors connected to Ishaan in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Ishaan Tewarie work?
- Ishaan Tewarie is Vice President at EQT Life Sciences.
- What check size does Ishaan Tewarie write?
- Ishaan Tewarie typically writes checks of $11M – $65M.
Same school
Also attended Harvard Medical School135
Niko BonatsosInvestment Team at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 129 more
Also attended Erasmus University Rotterdam177
Alessandro TavecchioPartner at P101 VenturesDick SietsesInvestment Partner Health at Capricorn Venture PartnersKonradInvestment Team at Hummingbird VenturesProf. Dr. Elbert DijkgraafBestuurslid at NoaberJohanneke van de Scheur-BaanBestuurslid at NoaberMaarten FischerHead of Programs at Noaber
+ 171 more
Shared employers
Also worked at Vico Therapeutics3
Also worked at NWO (Dutch Research Council)3
Also worked at Harvard Medical School162
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux Capital
+ 156 more
